A Study to Evaluate the Efficacy and Safety of a Vaccine, ASP0113, in Cytomegalovirus (CMV)-Seronegative Kidney Transplant Recipients Receiving an Organ From a CMV-Seropositive Donor
Clinical trial NCT01974206 · COMPLETED
Trial details
- NCT number
- NCT01974206
- Sponsor
- Astellas Pharma Global Development, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-11-20
- Primary completion
- 2016-05-13
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.